Anthony Pare
No más puestos en curso
Fortuna: - $ al 30/04/2024
Perfil
Anthony Pare served as the Chief Executive Officer at Bioporto A from 2021 to 2024.
Prior to that, he was the Chief Commercial Officer at Hemanext, Inc. and T2 Biosystems, Inc. He also held the position of VP & General Manager-Global Services at Haemonetics Corp.
In terms of education, he received a graduate degree from George Washington University and an undergraduate degree from Maine Maritime Academy.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOPORTO A/S
-.--% | 31/12/2022 | 0 ( -.--% ) | - $ | 30/04/2024 |
Antiguos cargos conocidos de Anthony Pare.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOPORTO A/S | Director Ejecutivo | 09/01/2024 |
| T2 BIOSYSTEMS, INC. | Corporate Officer/Principal | 08/11/2021 |
Hemanext, Inc.
 Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
| HAEMONETICS CORPORATION | Corporate Officer/Principal | - |
Formación de Anthony Pare.
| Maine Maritime Academy | Undergraduate Degree |
| George Washington University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| T2 BIOSYSTEMS, INC. | Health Technology |
| BIOPORTO A/S | Health Technology |
| Empresas privadas | 1 |
|---|---|
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Anthony Pare
